Your browser doesn't support javascript.
loading
Harmonization of distributed multi-center analysis based on dried blood spot reference materials supporting the screening of neonatal inherited metabolic disorders.
Qu, Shou-Fang; Tao, Hao-Ran; Qin, Liu-Ji; Zhang, Wen-Xin; Han, Shan; Zhang, Shen-Yan; Huang, Jie.
Afiliación
  • Qu SF; Division of Diagnostic for Non-infectious Disease, National Institutes for food and drug Control (NIFDC), Institute for in Vitro Diagnostic Control, Beijing, China.
  • Tao HR; BGI Genomics, Shenzhen, China.
  • Qin LJ; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Zhang WX; BGI Genomics, Shenzhen, China.
  • Han S; Division of Diagnostic for Non-infectious Disease, National Institutes for food and drug Control (NIFDC), Institute for in Vitro Diagnostic Control, Beijing, China.
  • Zhang SY; GBI Biotech, BGI Genomics, Beijing, China.
  • Huang J; BGI Genomics, Shenzhen, China.
J Clin Lab Anal ; 37(19-20): e24970, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37837220
ABSTRACT

BACKGROUND:

The standardization of quantification data is critical for ensuring the reliability and measurement traceability in the screening of neonatal inherited metabolic disorders. However, the availability of national certified reference materials is limited in China.

METHODS:

In this study, we developed a series of dried blood spot (DBS) reference materials containing 9 amino acids (AA) and 10 acylcarnitines (AC) for neonatal screening. Four levels of the reference materials were measured with tandem mass spectrometry (MS/MS) by seven laboratories using different commercial In Vitro Diagnostic Device (IVD) kits. Then, 100 clinical samples were measured using both derivatization and non-derivatization methods by the same laboratory.

RESULTS:

We found high homogeneity and stability at all levels of the reference materials, with the coefficient of variation (CV) of the analytes less than 15%. These reference materials can be used to assess the testing capabilities of different laboratories. Our test also revealed that the correction factors (CF) calculated by the reference materials, along with clinical samples, could increase the consistency for different kits.

CONCLUSION:

The DBS reference materials proposed in this study provide reliability for the harmonization in multi-center analysis for the screening of neonatal inherited metabolic disorders. And applying our correction method for the screening could improve the data consistency of the DBS samples prepared by different methods.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades del Recién Nacido / Enfermedades Metabólicas Límite: Humans / Newborn Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades del Recién Nacido / Enfermedades Metabólicas Límite: Humans / Newborn Idioma: En Año: 2023 Tipo del documento: Article